The stock of Geron Corp. (NASDAQ:GERN) last traded at $3.31, down -0.60% from the previous session.
GERN stock price is now 53.90% away from the 50-day moving average and 39.83% away from the 200-day moving average. The market capitalization of the company currently stands at $1.81B.
With the price target enhanced from $4 to $5, Needham maintained Buy rating for Geron Corp. (NASDAQ: GERN). On September 12, 2023, Goldman Upgraded its previous ‘Neutral’ rating to ‘Buy’ on the stock keeping its target price maintained at $4, while ‘Wedbush’ rates the stock as ‘Outperform’
In other news, O’Farrell Elizabeth G., Director bought 6,607 shares of the company’s stock on Aug 24 ’23. The stock was bought for $15,064 at an average price of $2.28. Upon completion of the transaction, the Director now directly owns 7,407 shares in the company, valued at $24517.17. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 24 ’23, Director O’Farrell Elizabeth G. bought 6,579 shares of the business’s stock. A total of $15,000 was incurred on buying the stock at an average price of $2.28. This leaves the insider owning 26,220 shares of the company worth $86788.2. A total of 18.03% of the company’s stock is owned by insiders.
During the past 12 months, Geron Corp. has had a low of $1.64 and a high of $3.73. As of last week, the company has a debt-to-equity ratio of 0.35, a current ratio of 3.16, and a quick ratio of 3.16. The fifty day moving average price for GERN is $2.1684 and a two-hundred day moving average price translates $2.3565 for the stock.
The latest earnings results from Geron Corp. (NASDAQ: GERN) was released for Dec, 2023. According to the Biotechnology Company, earnings per share came in at -$0.09, beating analysts’ expectations of -$0.1 by 0.01. This compares to -$0.11 EPS in the same period last year. The net profit margin was -77691.14% and return on equity was -112.29% for GERN. The company reported revenue of $23000.0 for the quarter, compared to $0.1 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -77.67 percent. For the current quarter, analysts expect GERN to generate $30k in revenue.
